PANSAID - PAracetamol and NSAID in combination: study protocol for a randomised trial

Keyphrases

• Randomized Trial 100%
• Paracetamol 100%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 100%
• Combination Studies 100%
• Placebo 40%
• Number of Patients 40%
• Total Hip Arthroplasty 40%
• Morphine 40%
• Alcohol 20%
• Adverse Events 20%
• Placebo-controlled 20%
• Intervention Group 20%
• Multicenter Trial 20%
• After Surgery 20%
• Monotherapy 20%
• Inclusion Criteria 20%
• Analgesic Effect 20%
• Drug Abuse 20%
• Postoperative Pain Management 20%
• Pain Score 20%
• Surgical Patients 20%
• Informed Consent 20%
• Serious Adverse Events 20%
• Block Size 20%
• Statistician 20%
• Analgesic Efficacy 20%
• Allergy 20%
• Caregivers 20%
• Daily Use 20%
• EudraCT 20%
• Allocation Concealment 20%
• Primary Total Hip Arthroplasty 20%
• Co-primary 20%
• No Gold Standard 20%
• Strong Opioids 20%
• Exclusion Criteria 20%
• Non-opioid 20%
• Type I Error Rate 20%
• Additional Analgesics 20%
• Manuscript Submission 20%
• Type II Error Rate 20%
• ASA Status 20%

Medicine and Dentistry

• Nonsteroid Antiinflammatory Agent 100%
• Ibuprofen 100%
• Paracetamol 100%
• Placebo 60%
• Total Hip Arthroplasty 60%
• Drug Therapy 40%
• Adverse Event 40%
• Morphine 40%
• Rehabilitation Engineering 20%
• Body Mass Index 20%
• Analgesic Activity 20%
• Drug Abuse 20%
• Acetylsalicylic Acid 20%
• Contraindication 20%
• Opiate 20%
• Postoperative Pain 20%
• Monotherapy 20%
• Analgesic Efficacy 20%
• Analgesia 20%
• Informed Consent 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Paracetamol 100%
• Non-Steroidal Anti-Inflammatory Drug 100%
• Ibuprofen 100%
• Placebo 60%
• Adverse Event 40%
• Analgesic Agent 40%
• Morphine 40%
• Ethanol 20%
• Monotherapy 20%
• Postoperative Pain 20%
• Acetylsalicylic Acid 20%
• Opiate 20%